News
A diagnostic tool is needed for clinicians to identify high-risk OS in advance. The purpose of this study is to develop a classifier capable of accurately predicting the high-risk OS subtype using ...
13d
TipRanks on MSNVeracyte reports Phase 3 STAMPEDE trial finding published in Cell
Veracyte (VCYT) and University College London announced that data published online in Cell show that the Decipher Prostate Genomic Classifier ...
"Our findings suggest that the Decipher Prostate test may provide an important new tool to help guide treatment decisions for the growing population of patients with metastatic prostate cancer," said ...
Yusuf Roohani, PhD, machine learning group lead at the Arc Institute, is among a team of researchers training artificial intelligence (AI) models with transcriptome data to predict how cell gene ...
Company announces acquisition of Aster Insights, a move that creates a first-of-its-kind enterprise aimed at accelerating the development of cancer therapiesMCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results